So long, Plavix, what a ride! Clopidogrel patent expires
Features
So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT
Expiration of the clopidogrel patent draws a close to a "fascinating era" in cardiovascular medicine, say experts, having had its largest impact in the ACS and poststenting settings. Yet even as the patent expires there remain some unanswered questions, particularly given the emergence of platelet function and genetic testing for clopidogrel metabolism.
Arrhythmia/EP
Apixaban cuts stroke risk in all types of AF, says ARISTOTLE
May 16, 2012 09:30 EDT
The trial also had something to say about the degree of stroke risk according to type of atrial fibrillation—that is, whether paroxysmal or permanent/persistent.
Imaging
FAME II: FFR pinpoints stable CAD patients who fare worse with OMT
4 COMMENTS - May 15, 2012 09:00 EDT
Preliminary data showing urgent revascularizations to be more than 10 times higher in patients treated with optimal medical therapy instead of PCI were what prompted the data safety and monitoring board to halt FAME II.
heartbriefs
heartbriefs
View all »

Editorial series

Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Starting with ASCERT, a look at observational studies
Editorial series
Starting with ASCERT, a look at observational studies
May 8, 2012 08:53 EDT
Dr Harlan Krumholz talks to Dr Bob Harrington about ASCERT and the questions it raises about using observational studies to look at comparative effectiveness.
Are appropriate-use criteria for coronary revascularization advancing patient care?
Editorial series
Are appropriate-use criteria for coronary revascularization advancing patient care?
Apr 30, 2012 08:20 EDT
On the tail of the recent update to the original document on the appropriate use of revascularization and surgery, our panel gathered to discuss the initiative and address whether patient outcomes are being improved by it.
The creative destruction of medicine with Dr Eric Topol
Editorial series
The creative destruction of medicine with Dr Eric Topol
Apr 24, 2012 13:30 EDT
Medicine is about to go through its biggest shake-up in history. Learn more about Dr Eric Topol's take on the future of healthcare.
Statins, diabetes, and the FDA
Editorial series
Statins, diabetes, and the FDA
4 COMMENTS - Apr 17, 2012 13:00 EDT
Is the diabetes signal real? Join Drs Darren McGuire, Paul Thompson, and Sanjay Kaul as they discuss the recent FDA labeling changes related to statins.
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors

Digital Man
Digital Man
Time to retire the Holter monitor? Long-term cardiac rhythm monitoring comes of age
13 comments
Apr 26, 2012 09:45 EDT
What took so long? More than 60 years after the invention of the Holter monitor, new technologies are--finally!--stepping in to offer simple and innovative devices to monitor cardiac arrhythmias. Is this one a "keeper"?
Most recent posts
theheart.org forum theheart.org forum
Exchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Acute Coronary Syndromes
Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT
Lipid/Metabolic
Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT
Arrhythmia/EP
Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT
Interventional/Surgery
COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
Interventional/Surgery
COMPARE II: Nobori biolimus stent matches everolimus stents in all-comers
May 16, 2012 10:15 EDT
Medscape Medical News
FDA panel recommends lorcaserin for obesity
3 COMMENTS - May 15, 2012 15:45 EDT
Murmurs
William O'Neill goes home to lead new structural heart group at Henry Ford
1 COMMENT - May 15, 2012 13:45 EDT
Heart failure
TAVI to treat surgical valve failure shows potential, with caveats
May 15, 2012 13:00 EDT
Arrhythmia/EP
Resuscitation rates in out-of-hospital arrests are woeful
2 COMMENTS - May 15, 2012 11:30 EDT
Arrhythmia/EP
Without warfarin, Watchman still prevents strokes, says registry
May 15, 2012 10:15 EDT
Imaging
Stress echo in asymptomatic patients after revascularization "not worth it"
May 14, 2012 17:15 EDT
Most popular
  1. More adverse events seen on dabigatran vs warfarin
  2. WHF defends Dubai WCC, reimburses Israelis denied visas
  3. Dr David Rosenbaum dies, age 54, of pancreatic cancer
  4. Pfizer stops promoting Lipitor in US
  5. MRI with pacers, ICDs: Safe, a few minor issues, says MagnaSafe registry
  6. Moderate coffee intake protects against stroke
  7. Bypass moderate coronary lesions? Taking sides in the debate
  8. Dr Douglas Zipes explains his rare Riata editorial
  9. Roche stops dalcetrapib trial for lack of benefit
  10. Whistleblower suit claiming pioglitazone cover-up implicates Nissen, Cleveland Clinic
View all news »
  1. Roche stops dalcetrapib trial for lack of benefit
  2. Analyze this Doppler signal from a 45-year-old man with dyspnea
  3. More adverse events seen on dabigatran vs warfarin
  4. Bypass moderate coronary lesions? Taking sides in the debate
  5. Sudden cardiac death risk stratification in athletes
  6. Moderate coffee intake protects against stroke
  7. FAME II: FFR pinpoints stable CAD patients who fare worse with OMT
  8. Cheese, please: Could a little Grana Padano drop your BP?
  9. Femoral vs radial access: Rivals or complements?
  10. Dr David Rosenbaum dies, age 54, of pancreatic cancer
View all discussions »
Membership is free!
Like us
on facebook
Follow us
on twitter
Inside Themes
Interventional/Surgery
ACUTE MI
Featured program
Managing the Risk of Sudden Cardiac Death in Nonischemic Patients
RELEASE DATE: Mar 15, 2012
Arrhythmia/EP
AF Stroke Prevention
Featured program
A New Era in the Management of AF: An Update on Oral Anticoagulation
RELEASE DATE: Sep 27, 2011
Interventional/Surgery
Advances in Arterial Access
Featured program
Saving Limbs With an Endovascular Approach
RELEASE DATE: Mar 23, 2011
Acute Coronary Syndromes
Antiplatelet Therapies
Featured program
The Late Night Report: Medical Management of ACS: A Global Healthcare Problem
RELEASE DATE: Mar 19, 2012
Arrhythmia/EP
Arrhythmia & HF Management
Featured program
A Decade of CRT and ICD Use in HF: VENTAK CHF/CONTAK CD to RAFT
RELEASE DATE: Jun 23, 2011
Interventional/Surgery
Cathether Based Therapies
Featured program
TAVI Preprocedural Imaging: The Role of CT
RELEASE DATE: Feb 27, 2012
Hypertension
Comprehensive PAH Management
Featured program
The Importance of Catheterization in the Assessment of PH
RELEASE DATE: Dec 15, 2011
Interventional/Surgery
Drug-Eluting Stents
Featured program
The Complex Case of.Which Is the Culprit Lesion?
RELEASE DATE: Mar 08, 2012
Arrhythmia/EP
Emerging Approaches to HF
Featured program
Optimal Implementation of Evidence-Based HF Therapies on Mortality
RELEASE DATE: Sep 07, 2011
Lipid/Metabolic
Residual Risk Management
Featured program
Residual Cardiovascular Risk: Where Do You Stand?
RELEASE DATE: Mar 02, 2012
Hypertension
Resistant Hypertension
Featured program
The Many Faces of the Global Epidemic of Hypertension
RELEASE DATE: Feb 02, 2012
Clinical cardiology
Stable Ischemic Heart Disease
Featured program
PAH: Revealing and Addressing Treatment Gaps
RELEASE DATE: Nov 18, 2011
Interventional/Surgery
Stents, Structure and Stenosis
Featured program
Advances in Wire Technology: Improving Procedural Efficiency
RELEASE DATE: Jan 25, 2012
Clinical Cardiology
T2DM Management: The Kidneys Matter
Featured program
Can We Ever Not Be Concerned About Worsening Kidney Function?
RELEASE DATE: Apr 04, 2012
Acute Coronary Syndromes
Thrombosis in ACS
Featured program
A New Standard of Care in ACS: Potent P2Y12 Inhibition
RELEASE DATE: Feb 02, 2012
Academic collaboration
Mayo Clinic joins forces with theheart.org to provide unique perspective on clinical trials, patient care, news, and events in cardiology

Mayo Clinic resource page »
Press center
Latest cardiology-related press releases and communications from industry
Poll
US cardiologists, on average, made $314 000 in 2011. Is this:
Too much
Too little
Just right

See: Cardiologists still earning big bucks, but work frustration abounds
Vote
Also on theheart.org
The ACC 2012 Roundup: PARTNER A, TRA 2°P, STAMPEDE, ROMICAT II, and ACRIN-PA
The Cardiology Show
The ACC 2012 Roundup: PARTNER A, TRA 2°P, STAMPEDE, ROMICAT II, and ACRIN-PA
1 COMMENT - Mar 28, 2012 11:18 EDT
Dr Valentin Fuster sits down with Drs Pamela Douglas, Bob Harrington, Harlan Krumholz, Jorge Plutzky, Josep Rodés-Cabau, and James Stein for an in-depth discussion on the important trials presented at the ACC 2012 Scientific Sessions.
Statin safety: theheart.org reader's survey
Editorial series
Statin safety: theheart.org reader's survey
23 COMMENTS - Mar 14, 2012 16:30 EDT
theheart.org conducted a survey to gauge cardiologists' opinions on statin safety following an FDA-mandated labeling change, warning that the drugs may increase blood glucose and HbA1c and potentially lead to reversible memory loss/confusion. Here's what they told us.